NASDAQ / LIVE COMPANY INTELLIGENCE

Cyclerion Therapeutics, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERCYCN
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / CYCN COVERAGE

What’s moving Cyclerion Therapeutics, Inc. now

Current reporting with the operating signal separated from the noise.

01
CYCN Stock Alert: Halper Sadeh LLC is Investigating Whether Cyclerion Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders

CYCN Stock Alert: Halper Sadeh LLC is Investigating Whether Cyclerion Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders

Investors are testing whether Cyclerion Therapeutics, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
02
Cyclerion Therapeutics, Inc. (CYCN) M&A Call Prepared Remarks Transcript

Cyclerion Therapeutics, Inc. (CYCN) M&A Call Prepared Remarks Transcript

The story matters when it changes Cyclerion Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Cyclerion Therapeutics, Inc. (CYCN) Discusses Medsteer Development Collaboration and Updates on Phase 2 Proof-of-Concept Study in Treatment-Resistant Depression Prepared ...

Cyclerion Therapeutics, Inc. (CYCN) Discusses Medsteer Development Collaboration and Updates on Phase 2 Proof-of-Concept Study in Treatment-Resistant Depression Prepared ...

The story matters when it changes Cyclerion Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
Is Cyclerion Therapeutics, Inc. (CYCN) A Good Stock To Buy?

Is Cyclerion Therapeutics, Inc. (CYCN) A Good Stock To Buy?

Investors are testing whether Cyclerion Therapeutics, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
05
Cyclerion Therapeutics, Inc. (CYCN) Is Burning These Hedge Funds

Cyclerion Therapeutics, Inc. (CYCN) Is Burning These Hedge Funds

The story matters when it changes Cyclerion Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest CYCN filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-08-04 · Period 2026-06-30SEC ↗10-QQuarterly financial reportFiled 2026-05-12 · Period 2026-03-31SEC ↗10-K/AAnnual financial reportFiled 2026-04-30 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-04-01 · Period 2026-04-01SEC ↗8-KMaterial company eventFiled 2026-02-17 · Period 2026-02-17SEC ↗8-KMaterial company eventFiled 2026-01-06 · Period 2026-01-03SEC ↗DEF 14AProxy and shareholder meetingFiled 2025-04-29 · Period 2025-06-16SEC ↗425Official SEC filingFiled 2026-08-03SEC ↗
EARNINGS / QUARTERLY TRACKER

Cyclerion Therapeutics, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.